布地奈德联合复方异丙托溴铵治疗儿童喘息性支气管炎疗效观察

Effect of budesonide combined with compound ipratropium in treating children with asthmatic bronchitis

目的评估布地奈德联合复方异丙托溴铵治疗儿童喘息性支气管炎的临床疗效。方法选取2017年7月至2019年3月本院收治的66例肺炎喘息性支气管炎患儿,随机分为治疗组(布地奈德联合复方异丙托溴铵治疗)33例,对照组(布地奈德治疗)33例,均予氧驱雾化吸入,比较两组临床症状评分及平均住院时间,并进行统计。结果两组治疗均可改善患儿的临床症状,治疗组临床症状评分低于对照组(P<0.05),治疗组平均住院时间优于对照组,两者比较差异有统计学意义(P<0.05)。结论雾化吸入复方异丙托溴铵联合布地奈德具有良好的疗效,单纯布地奈德改善病情效果不及联合复方异丙托溴铵,两者联用能更有效缓解临床表现。

Objective To evaluate the clinical efficacy of budesonide combined with compound ipratropium in the treatment of children with asthmatic bronchitis.Methods 66 cases of children with pneumonic asthmatic bronchitis were divided into 33 cases(budesonide combined with com pound ipratropium bromide treatment)and 33 cases(budesonide treatment),all of which were given oxygen drive.Fog inhalation,the clinical symptom score and average length of hospitalization were compared between the two groups.Results Both groups could improve the clinical symptoms of the children,and the clinical symptom score of the treatment group was lower than that of the control group(P<0.05).The average length of hospitalization in the treatment group was better than that in the control group,and the difference was statistically significant(P<0.05).Conclusion Fogging inhalation compound ipratropium combined with budesonide has a good effect,simple budesonide improved the condition less than compound ipratropium,the combination of the two more effective to alleviate clinical performance.